NCT05590195View on ClinicalTrials.gov

Effect of PreforPro® on Urinary and Vaginal Health

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

June 1, 2025

Conditions
Bacterial VaginosisBacterial InfectionsBacterial Vaginosis | Vaginal | MicrobiologyVaginal Infection
Interventions
DRUG

Preforpro

Preforpro will be investigated to improve vaginal health in women with BV.

OTHER

Placebo

Placebo capsules manufactured to look like Preforpro capsules

All Listed Sponsors
collaborator

Deerland Enzymes

INDUSTRY

collaborator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

collaborator

St. Joseph's Health Care London

OTHER

lead

Jeremy Burton

OTHER